Retrotope

Series-B+
retrotope.com Biotech & Healthcare
Total Funding $20M
Latest Round Undisclosed Series-B+
Last Announced Aug 27, 2021
Investors Undisclosed
Decision Makers 6 Verified

About Retrotope

Retrotope is developing a pipeline of proprietary therapeutics designed to treat degenerative disease by down-regulating LPO in order to protect against cellular degeneration.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website retrotope.com
Domain Registered Date May 15, 2008

Social & Network Presence

X / Twitter Profile @Retrotope1 (31 followers) Created on Dec 2017
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-B+ announced

    startupintros.com

  2. Capital Raise

    Raised $20,000,000 · Series-B+

    startupintros.com

  3. Milestone

    X account created (@Retrotope1)

    31 followers

  4. Milestone

    Website domain registered

    retrotope.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Retrotope.

Funding History

2 Rounds
Series-B+ · Aug 27, 2021
Series-B+ · Jul 19, 2019

Founders & Leadership

1

Mikhail S. Shchepinov

Founder and CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts